Moore Kuehn Encourages MXIM, CGIX, PTI, and DCOM Investors to Contact Law Firm

NEW YORK, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies:

A registration statement was recently filed with the SEC regarding Analog Devices, Inc.’s acquisition of Maxim Integrated, which may omit material information regarding the financial metrics and analyses used to evaluate the merger.  Under the proposed transaction, shareholders of Maxim will 0.630 of a share of Analog for every share owned.

Cancer Genetics has agreed to merge with StemoniX.  Under the proposed transaction, Cancer Genetics will issue shares of common stock to the owners of StemoniX, with current holders of Cancer Genetics common stock controlling only 22% of the combined company.

Proteostasis Therapeutics has agreed to merge with Yumanity Therapeutics.  Under the proposed transaction, current holders of Proteostasis Therapeutics common stock will only control 32.5% of the combined company.

Dime has signed an agreement to merge with Bridge Bancorp, Inc. Under the proposed transaction, shareholders of Dime will receive 0.6480 shares of Bridge Bancorp for every share owned.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. 

Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at or telephone at (212) 709-8245.  The consultation and case are free with no obligation to you.    Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

Moore Kuehn is a 5-star New York City-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please go to

Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
(212) 709-8245

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.